Health
Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes – News-Medical.Net
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Reviewed by Emily Henderson, B.Sc.Nov 16 2020
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors has been mounting, with studies showing better blood glucose control, cardiovascular benefits, weight loss and more for patients with diabetes taking SGLT2 inhibitors.
Now, two large clinical trials, conducted by investigators at…
-
Noosa News22 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General22 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General11 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News14 hours agoNew playground equipment encourages children to learn through ‘risky play’